14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for MRNS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.72 13.69 %
R2 1.65 9.39 %
R1 1.61 6.73 %
Current price: 1.51
Support S1 1.48 -1.87 %
S2 1.44 -4.53 %
S3 1.38 -8.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.51
Support S1 1.44 -4.64%
S2 1.30 -13.91%
S3 1.20 -20.53%

MRNS Predictions History

6 years ago
JuanC Villegas predicted that MRNS for 2017-09-26 is going $5.61 (2.56%)

7 years ago
Adrian predicted that MRNS for 2017-04-04 is going $1.55 (-8.82%)

Rank:

7 years ago
Reese predicted that MRNS for 2017-03-15 is going $0.713 (-54.00%)

Rank:

7 years ago
JS predicted that MRNS for 2017-03-10 is going $1.66 (3.75%)

7 years ago
Jack.Cesario.Migueis.3576 predicted that MRNS for 2017-03-10 is going $1.44 (-10.00%)

7 years ago
GeniusNinja predicted that MRNS for 2017-03-10 is going $1.55 (-3.13%)

Rank:

7 years ago
JS predicted that MRNS for 2017-02-17 is going $1.48 (1.37%)

7 years ago
JS predicted that MRNS for 2016-11-25 is going $1.09 (-6.03%)

7 years ago
John.Salery.1158 predicted that MRNS for 2016-10-05 is going $1.50 (-6.25%)

Rank:

7 years ago
John.Salery.1158 predicted that MRNS for 2016-10-04 is going $2.87 (63.07%)

Rank:
Click to get the best stock tips daily for free!

About Marinus Pharmaceuticals

Marinus Pharmaceuticals Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The... MRNS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT